Press releases

PARIS, FRANCE, AND MINNEAPOLIS, MN - June 14, 2014 - Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS - June 12, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for patients...

MINNEAPOLIS - June 11, 2014 - The board of directors of Medtronic, Inc. (NYSE: MDT), announced that the company's annual meeting of shareholders will be held at 10:30 a.m. CDT on Thursday, Aug....

MINNEAPOLIS - Date - Moving toward U.S. market introduction of its novel medical device to treat peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced that it recently submitted...

DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 10, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration (FDA) approval of its Apollo™ Onyx™ delivery micro catheter - the...

MINNEAPOLIS - June 10, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Healthcare Conference on Tuesday,...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS -- Jun. 5, 2014 -- Medtronic, Inc. (NYSE: MDT) shared during its Investor Conference today in New York City an overview of the state of its business and strategies for future growth...

HeartWare International, Inc. (Nasdaq: HTWR) announced that on June 3, 2014 it received a warning letter from the U.S. Food and Drug Administration (FDA) resulting from an inspection of the...